NCT03260426

Brief Summary

Prospective randomized controlled trial investigating commencement of low residue diet versus clear liquids on postoperative zero following elective colorectal surgery, with regards to patient tolerability, incidence of nausea and/or vomiting, and postoperative length of hospitalization stay.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 16, 2017

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

August 18, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 24, 2017

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2018

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

January 31, 2020

Completed
Last Updated

January 31, 2020

Status Verified

January 1, 2020

Enrollment Period

12 months

First QC Date

August 18, 2017

Results QC Date

October 30, 2019

Last Update Submit

January 17, 2020

Conditions

Keywords

Tolerability diet after surgery

Outcome Measures

Primary Outcomes (1)

  • Number of Participants Who Experienced Emesis on Post Operative Day 2

    Patient tolerability, as evidenced by development of vomiting on postoperative day two.

    POD 2

Secondary Outcomes (7)

  • Number of Participants Able to Tolerate a Regular Diet as Compared to a Clear Liquid Diet on Post Operative Day 0 (POD 0).

    POD 0

  • Antiemetic Usage

    30 days

  • Hospital Stay

    30 days

  • Post-operative Ileus

    30 days

  • Pain Score

    POD 1 and POD 2 and Discharge

  • +2 more secondary outcomes

Study Arms (2)

Clear Liquid Diet

EXPERIMENTAL

Clear liquids on postoperative day zero and intestinal rate measured by Abstats

Dietary Supplement: Clear LiquidsDevice: Abstats

Regular Solid Diet

EXPERIMENTAL

Regular diet from postoperative day zero and intestinal rate measured by Abstats

Dietary Supplement: Regular SolidDevice: Abstats

Interventions

Clear LiquidsDIETARY_SUPPLEMENT

Clear liquids on postoperative day zero immediately upon return to the floor and subsequent days' advancement of enteral diet to regular diet is as per discretion of the attending physician.

Clear Liquid Diet
Regular SolidDIETARY_SUPPLEMENT

Regular diet from postoperative day zero immediately upon return to floor and onwards

Regular Solid Diet
AbstatsDEVICE

Intestinal rate measured by Abstats™ in patients offered immediate solid versus clear liquids after colorectal surgery

Clear Liquid DietRegular Solid Diet

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to freely give written informed consent to participate in the study and have signed the Informed Consent Form;
  • Males or females, \>18 years of age inclusive at the time of study screening;
  • American Society of Anesthesiologists (ASA) Class I-III;
  • Colorectal surgery (open and/or robotic/laparoscopic);
  • Elective Surgery

You may not qualify if:

  • Mentally incompetent or unable or unwilling to provide informed consent or comply with study procedures.
  • Children \<18 years of age.
  • Pre-operative clinical diagnosis of intestinal obstruction.
  • Pre-existing known upper gastrointestinal disorders including hiatus hernia, gastroesophageal reflux disease, peptic ulcer disease.
  • Pre-existing oropharyngeal disorders such as stomatitis, altered taste sensations.
  • Colorectal surgery with concomitant resectional surgery of the stomach or proximal jejunum (small bowel).
  • Pregnant patients.
  • Bedbound or moribund patients.
  • Pre-existing history of clinical depression.
  • Epidural analgesia.
  • Surgical procedures completed after 4pm
  • Patients taking narcotics prior to elective colorectal surgery
  • Postoperative diagnosis of intra-abdominal sepsis, including anastomotic leaks.
  • Postoperative complications requiring early reoperation within the same hospital stay.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cedars Sinai Medical Center

Los Angeles, California, 90048, United States

Location

Related Publications (3)

  • Lau C, Phillips E, Bresee C, Fleshner P. Early use of low residue diet is superior to clear liquid diet after elective colorectal surgery: a randomized controlled trial. Ann Surg. 2014 Oct;260(4):641-7; discussion 647-9. doi: 10.1097/SLA.0000000000000929.

    PMID: 25203881BACKGROUND
  • Spiegel BM, Kaneshiro M, Russell MM, Lin A, Patel A, Tashjian VC, Zegarski V, Singh D, Cohen SE, Reid MW, Whitman CB, Talley J, Martinez BM, Kaiser W. Validation of an acoustic gastrointestinal surveillance biosensor for postoperative ileus. J Gastrointest Surg. 2014 Oct;18(10):1795-803. doi: 10.1007/s11605-014-2597-y. Epub 2014 Aug 5.

    PMID: 25091837BACKGROUND
  • Yao LY, Gough AE, Zaghiyan KN, Fleshner PR. Prospective Randomized Trial of Immediate Postoperative Use of Regular Diet Versus Clear Liquid Diet in Major Colorectal Surgery. Dis Colon Rectum. 2023 Dec 1;66(12):1547-1554. doi: 10.1097/DCR.0000000000002737. Epub 2023 Aug 31.

MeSH Terms

Conditions

NauseaVomiting

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Phillip Fleshner, MD
Organization
Cedars Sinai Medical Center

Study Officials

  • Phillip Fleshner, MD

    Cedars-Sinai Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor of Surgery

Study Record Dates

First Submitted

August 18, 2017

First Posted

August 24, 2017

Study Start

August 16, 2017

Primary Completion

July 31, 2018

Study Completion

July 31, 2018

Last Updated

January 31, 2020

Results First Posted

January 31, 2020

Record last verified: 2020-01

Locations